Mesothelioma trials recruiting in Maryland

All Mesothelioma trials nationally

Cities in Maryland

Recruiting trials in Maryland

• 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
  NCT06503146 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
  NCT06885697 · Phase: Phase 1 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
  NCT05960773 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
  NCT05627960 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Integrated Cancer Repository for Cancer Research
  NCT02012699 · Phase: Not specified · Ages: 19 Years to 110 Years · Sex: All (male and female) · Maryland: Randallstown, Westminster
• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
  NCT05579366 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Rockville
• Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
  NCT01950572 · Phase: Not specified · Ages: 2 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda